ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,440.80
2.14%
다우존스 지수
38,675.68
1.18%
Bitcoin
62,767.50
6.17%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. IGM Biosciences Inc (IGMS)

  7. IGM Biosciences Inc (IGMS) 뉴스

IGMS IGM Biosciences Inc

10.07
0.64 (6.79%)
시간외 거래
최종 업데이트: 05:59:48
15분 지연
기업명 주식 심볼 시장 주식 타입
IGM Biosciences Inc IGMS 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.64 6.79% 10.07 05:59:48
개장가 저가 고가 종가 전일 종가
9.73 9.72 10.19 10.07 9.43
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
17/04/202421:30GLOBEIGM Biosciences Announces Refocusing of Sanofi Collaboration
10/04/202420:00GLOBEIGM Biosciences to Present at the Stifel 2024 Virtual..
08/03/202406:27EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/03/202406:10EDGAR2Form 8-K - Current report
08/03/202406:10GLOBEIGM Biosciences Announces Fourth Quarter and Full Year 2023..
06/03/202409:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202421:00GLOBEIGM Biosciences to Present at the Guggenheim Healthcare..
08/01/202423:00EDGAR2Form 8-K - Current report
04/01/202410:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202408:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202408:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/01/202421:00GLOBEIGM Biosciences to Present at the 42nd Annual J.P. Morgan..
16/12/202309:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202309:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202309:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202307:36EDGAR2Form 144 - Report of proposed sale of securities
14/12/202307:33EDGAR2Form 144 - Report of proposed sale of securities
14/12/202307:30EDGAR2Form 144 - Report of proposed sale of securities
14/12/202307:27EDGAR2Form 144 - Report of proposed sale of securities
09/12/202306:05EDGAR2Form 8-K - Current report
06/12/202306:01GLOBEIGM Biosciences Announces Strategic Pipeline Prioritization..
02/12/202309:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202309:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202309:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202319:32PRNUSBulletin from Extraordinary General Meeting in Medivir AB..
30/11/202310:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202310:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202310:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
21/11/202316:48PRNUSMedivir to present at the Erik Penser Bank Company Event
14/11/202307:08EDGAR2Form S-3 - Registration statement under Securities Act of..
14/11/202306:10EDGAR2Form 8-K - Current report
14/11/202306:10GLOBEIGM Biosciences Announces Third Quarter 2023 Financial..
14/11/202306:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202321:00GLOBEIGM Biosciences to Present at Two Upcoming Investor..
06/10/202308:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202308:42EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/10/202320:29PRNUSFostrox + Lenvima continues to show promising tumor control..
04/10/202309:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202308:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202308:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202308:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202305:14EDGAR2Form 8-K - Current report
04/10/202305:05GLOBEIGM Biosciences Announces Retirement of Chairman Michael..
03/10/202305:27EDGAR2Form 144 - Report of proposed sale of securities
06/09/202320:00GLOBEIGM Biosciences to Present at the Morgan Stanley 21st Annual..
04/08/202305:13EDGAR2Form 8-K - Current report
04/08/202305:10GLOBEIGM Biosciences Announces Second Quarter 2023 Financial..
04/08/202305:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
20/07/202305:13EDGAR2Form SC 13D/A - General statement of acquisition of..

최근 히스토리

NASDAQ
IGMS
IGM Biosciences
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유